Marshall Wace’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-87,200
Closed -$13.7M 2628
2023
Q4
$13.7M Buy
87,200
+2,300
+3% +$353K 0.02% 592
2023
Q3
$13.2M Buy
84,900
+15,700
+23% +$2.59M 0.03% 556
2023
Q2
$11.5M Sell
69,200
-6,600
-9% -$1.07M 0.02% 672
2023
Q1
$11.7M Sell
75,800
-168,600
-69% -$27.2M 0.03% 652
2022
Q4
$43.2M Buy
244,400
+15,800
+7% +$2.73M 0.1% 229
2022
Q3
$37.3M Buy
228,600
+216,100
+1,729% +$36.6M 0.08% 275
2022
Q2
$2.22M Buy
+12,500
New +$2.23M ﹤0.01% 1914
2022
Q1
Sell
-4,400
Closed -$752K 3676
2021
Q4
$752K Buy
+4,400
New +$720K ﹤0.01% 2615
2021
Q2
Sell
-1,400
Closed -$230K 2850
2021
Q1
$230K Buy
+1,400
New +$227K ﹤0.01% 2214

Other funds holding JNJ

Marshall Wace's JNJ Position: Q1 2026 in Review

Marshall Wace reduced its Johnson & Johnson (JNJ) stake by 35% in Q1 2026, selling an estimated $301M and leaving 2,377,822 shares worth $581M. The position accounts for 0.58% of the portfolio, ranked #15.

Marshall Wace first reported a position in JNJ in Q1 2014 and has held it in 42 quarters since. The position peaked at $854M in Q3 2024. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Marshall Wace held 2,377,822 shares of Johnson & Johnson worth $581M as of Q1 2026.
  • Marshall Wace sold 1,290,441 Johnson & Johnson shares in Q1 2026, an estimated $301M.
  • Johnson & Johnson made up 0.58% of Marshall Wace's portfolio in Q1 2026, its #15 holding.
  • Marshall Wace first reported a position in Johnson & Johnson in Q1 2014 and has held it in 42 quarters since.
  • Marshall Wace's Johnson & Johnson position peaked at $854M in Q3 2024.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.